In early August, Teva hit a bump in producing the popular ADHD drug Adderall, as the company faced a backorder of the drug in 20 mg and 30 mg ...

Senate Finance Committee Chair Ron Wyden (D-OR) is urging HHS to take a stronger stance on healthcare companies' cybersecurity practices as the healthcare system is still piecing together what ...

Mer­ck and Kelun-Biotech re­vealed Phase 3 breast can­cer da­ta for the lead an­ti­body-drug con­ju­gate in their po­ten­tial­ly $12 bil­lion part­ner­ship. In a Phase 3 tri­al … ...

April 29, 2024 05:53 PM EDT Updated 06:48 PM ...

Bristol Myers Squibb said its KRAS cancer drug Krazati met the primary endpoint in a Phase 3 confirmatory trial in patients with non-small cell lung cancer, according to new data ...

Madri­gal Phar­ma­ceu­ti­cals is “mak­ing great progress” on the roll­out of its NASH drug Rezd­if­fra, ex­ec­u­tives said less than a month post-launch. Rezd­if­fra was ...

Pacific Biosciences, or PacBio for short, made its name in long-read DNA sequencing — the technology recently used to sequence the entire human genome — filling in a ...

In the days fol­low­ing the US Supreme Court’s roll­back of fed­er­al abor­tion rights, more than 100 women biotech ex­ec­u­tives came to­geth­er in an ...

Up un­til re­cent­ly, Al­ban de La Sablière was Sanofi ’s chief deal­mak­er, re­port­ing di­rect­ly to CEO Paul Hud­son with­out of­fi­cial­ly be­ing a C-suite ex­ec­u­tive ...

December 14, 2021 08:34 AM EST Updated 09:29 AM ...

Un­der the gun with Aduhelm floun­der­ing, Bio­gen sells its stake in biosim­i­lars busi­ness for $2.3B ...

CVS Health is shut­ting down the clin­i­cal tri­als busi­ness that it launched just two years ago, part of an ef­fort to fo­cus on its core … ...